Related Experiment Videos

Effect of dipyrone, L-NAME and L-arginine on endotoxin-induced rat paw edema

J F Fracasso1, R L Nunes-de-Souza, C E Teixeira

  • 1Departamento de Princípios Ativos Naturais e Toxicologia, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, SP, Brasil. fracasso@boldo.fcf.ar.unesp.br

Insights

Endotoxin-induced paw edema in rats involves two phases. Early phase edema is prostaglandin-dependent, while the late phase is mediated by nitric oxide (NO) production.

Area of Science:

  • Pharmacology
  • Inflammation Research
  • Immunology

Background:

  • Paw edema is a common model for studying inflammation.
  • Endotoxin induces a biphasic inflammatory response in rat paws.
  • Early inflammatory mediators differ from those in later stages.

Purpose of the Study:

  • To investigate the mediators involved in the early and late phases of endotoxin-induced paw edema.
  • To determine the role of prostaglandins and nitric oxide (NO) in this inflammatory model.

Main Methods:

  • Paw edema was induced in Wistar rats using intraplantar endotoxin (Etx).
  • The effects of dipyrone and indomethacin on early phase edema were assessed.
  • The role of nitric oxide (NO) in the late phase was evaluated using N-omega-nitro-L-arginine methyl ester (L-NAME) and L-arginine.

Main Results:

  • Early phase edema was significantly reduced by dipyrone and indomethacin, suggesting prostaglandin involvement.
  • Late phase edema was inhibited by L-NAME (a nitric oxide synthase inhibitor) by 56%.
  • L-arginine (a NO precursor) administration increased edema by 81% and reversed L-NAME's inhibitory effect.

Conclusions:

  • Prostaglandins are key mediators in the early phase of endotoxin-induced paw edema.
  • Nitric oxide (NO) production plays a significant role in the late phase of this inflammatory response.
  • Targeting NO pathways may offer therapeutic strategies for managing late-stage inflammatory edema.

Related Concept Videos